Cisco Systems Inc. gave some more details on the timing of revenue from its anticipated orders related to artificial intelligence, and it looks like...
Shares in Coinbase Global soared Friday after the cryptocurrency broker’s fourth-quarter results comfortably beat Wall Street’s expectations. The company’s earnings also tell a story...
Amer Sports Inc., the Finnish sportswear company that went public last week, on Tuesday launched an offering of $600 million worth of seven-year high-yield...
OBSERVATIONS FROM THE FINTECH SNARK TANK Prediction: By the end of this decade, bank-fintech partnerships will be a thing of the past. This prediction...
During a challenging year for startups and financial institutions, these entrepreneurs, traders and investors are navigating tough terrain and making an outsized impact. By...
In the last three years, the banking and fintech sectors have undergone significant, foundational changes, profoundly impacting U.S. small businesses. Much of the talk...
The King is dead, long live the king. On Tuesday, November 21, Binance, what was the world’s largest cryptocurrency exchange, and the CEO, Changpeng...
Most global economies are slowing down. Purchasing Managers’ Indices (PMIs) are now declining around the world. On Friday, China’s National Bureau of Statistics announced...
Ring-a-ring o’ roses, Pockets stuffed with debtsies. Nudge-wink, Hush-Hush! We all fall down! I discussed debt formation in my previous article “Macroeconomic Review: When...
Investing.com — Most Asian currencies rose slightly on Tuesday as markets awaited more cues on U.S. monetary policy this week, while the Australian dollar...
Disclaimer: The Industry Talk section features insights by crypto industry players and is not a part of the editorial content of Cryptonews.com. The supply...
In the ever-evolving landscape of cloud-based applications and infrastructure, one company stands tall in shaping the future of observability use cases – Datadog (NASDAQ:DDOG)....
American depositary receipts of AstraZeneca were falling Monday after the drugmaker reported disappointing results from a Phase 3 trial of a lung-cancer drug. AstraZeneca...